pharmaphorum

MARCH 30, 2022

The SKYSCRAPER-02 showed that the combination of the two drugs given on top of chemotherapy was unable to improve progression-free survival versus Tecentriq (atezolizumab) plus chemo in extensive-stage SCLC – a notoriously hard-to-treat form of lung cancer.

Chemotherapy 97

Chemotherapy Immunity Immunization 97

pharmaphorum

DECEMBER 21, 2020

Boston, US-based Alexion spent a lot of 2019 arguing the merits of remaining independent, saying that while Soliris is approaching the end of its patent life – with heavyweight competitors like Amgen already eyeing the biosimilar market for the drug – Ultomiris and its pipeline could help drives sales to $9 to $10 billion in 2025.

Biosimilars 126

Biosimilars Chemotherapy Immunity Immunization 126

pharmaphorum

JANUARY 20, 2021

Sweden’s Sobi has secured EU approval for Doptelet in primary chronic immune thrombocytopenia (ITP), an indication that the company expects to accelerate sales of the drug. Sobi acquired Doptelet via its $915 million takeover of Dova Pharmaceuticals in 2019, adding to its haematology and rare disease franchise.

Chemotherapy 52

Chemotherapy Immunity Immunization 52

European Pharmaceutical Review

OCTOBER 19, 2023

Granzyme B is an enzyme released by activated immune cells and using this as a in vivo imaging biomarker has great potential to monitor immune cell activation in a variety of inflammatory diseases, autoimmune diseases, cancer and infections. What do you envision the future of radiopharmaceuticals to be like?

Chemotherapy 105

Chemotherapy Compounding Immunity Immunization 105

Pharmaceutical Technology

AUGUST 16, 2022

In 2019, Daiichi Sankyo entered a global development and commercialisation agreement with AstraZeneca for Daiichi Sankyo’s lead antibody-drug conjugate (ADC), Enhertu (trastuzumab deruxtecan), in a deal worth $6.9bn. months compared with patients treated with standard-of-care chemotherapy.

Chemotherapy 59

Chemotherapy Immunity Immunization 59

pharmaphorum

OCTOBER 4, 2021

Xencor has previously partnered with MorphoSys and Incyte to test plamotamab in combination with their CD19-targeted antibody Monjuvi (tafasitamab) – plus Bristol-Myers Squibb’s Revlimid (lenalidomide) – as a chemotherapy-free strategy for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), an aggressive type of NHL.

Chemotherapy 52

Chemotherapy Immunity Immunization 52

RX Note

AUGUST 4, 2023

You may also refresh knowledge of clinical pharmacokinetics , total parenteral nutrition or chemotherapy before entering the relevant rotations. You should be at least familiar with insulin and inhalers counselling before entering ward, inpatient or outpatient. What to do if I did not know the answer to questions from patients or doctors?

Hospitals 52

Hospitals Inpatient Community Pharmacies Dosage 52

The Thyroid Pharmacist

SEPTEMBER 20, 2024

Tenapanor : Tenapanor was approved by the FDA in September of 2019 for IBS-C. Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. April 24, 2019. Published 2019 Feb 12.

Health and Personal Care Stores 85

Health and Personal Care Stores Diabetes Chemotherapy Medication Therapy Management (MTM) 85

The Thyroid Pharmacist

NOVEMBER 4, 2022

12) For anyone looking to support immune health, hormone balance, and metabolic health, in addition to their thyroid, this is a great option. (37-39) Selenium may also interact with other supplements and medications, such as cholesterol-lowering statin drugs, antacids, chemotherapy drugs, corticosteroids, niacin, and even birth control pills.

Diabetes 98

Diabetes Dosage Compounding Immunity 98

European Pharmaceutical Review

DECEMBER 12, 2023

He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment. We specialise in the development of new cutting-edge immunotherapies , based on the use of therapeutic antibodies capable of activating the immune system to fight cancer.

Immunity 124

Immunity Immunization Chemotherapy Pharmaceutical Companies 124

STAT

JULY 24, 2023

Breast cancer has also shown an  accelerating increase  among women under 50, rising only slightly from 2000 to 2015 but increasing by 2 percent a year from 2015 to 2019. percent a year from 2017 to 2019; the yearly increase among women was 2.4 percent from 2000 to 2019.

Medical Schools 246

Medical Schools Hospitals Chemotherapy Immunity 246

pharmaphorum

JANUARY 3, 2023

Over recent years, there has been a growing consensus that using chemotherapy and aggressive treatments towards the end-of-life should be avoided, where possible, due to the lower quality of life reported. Once no cure can be found for a patient’s condition, decisions must be made about what is the most suitable path forwards.

Chemotherapy 105

Chemotherapy Immunity Immunization Hospitals 105

pharmaphorum

DECEMBER 18, 2020

Margenza (margetuximab) won FDA approval in combination with chemotherapy to treat metastatic HER2-positive breast cancer after at least two previous rounds of therapy. The median progression-free survival (PFS) of patients treated with Margenza and chemotherapy was 5.8 months in patients treated with trastuzumab and chemotherapy.

Chemotherapy 52

Chemotherapy Biosimilars Immunity Immunization 52

Pharmaceutical Technology

MARCH 2, 2023

Keytruda is indicated in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients whose tumors express PD-L1 and who have received at least one prior chemotherapy regimen. It is also indicated for the treatment of metastatic transitional (urothelial) tract cancer and gastric cancer.

Chemotherapy 40

Chemotherapy Vaccines Immunity Diabetes 40

pharmaphorum

AUGUST 22, 2022

. “Effectively, they create antibodies that can train one’s immune system to go after a specific cancer cell. Chemotherapy, the current standard of care for cancer treatment, can be harmful to both the cancer cells and the body’s healthy cells. So, it’s a highly personalised disease,” Torrance states.

Vaccines 102

Vaccines Chemotherapy Immunity Immunization 102

The Thyroid Pharmacist

AUGUST 26, 2022

28,29-33) Gut infections can impact nutrient absorption, metabolism, mitochondrial health, and the immune system. (28) These types of infections impact the immune system and can become triggers for autoimmunity; they can also disrupt ongoing metabolic processes. Published 2019 Aug 31. 2019 May 15;150:145-152.

Diabetes 98

Diabetes Immunity Immunization Chemotherapy 98

The Thyroid Pharmacist

JULY 8, 2022

Selenium is vital to our body’s ability to convert T4 to T3, and has a balancing effect on our thyroid and immune health. There are many different types of selenoproteins that focus on different functions relating to thyroid and immune system support. Why such an impact on so many? This is how autoimmunity starts. percent felt worse.

Dosage 59

Dosage Immunity Immunization Diabetes 59

RX Note

FEBRUARY 23, 2023

- Discussing the 4 main drug targets Functional Groups - Quick refresh on IUPAC nomenclature Drug Potency - Refresh on drug potency Drug Metabolism - Discussing Phase I and II reactions, as well as CYP450 system Pharmacogenomics - Discussing some examples Miscellaneous Continuous Professional Development - Needed for renewal of annual retention Immunization (..)

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

Pharmaceutical Technology

AUGUST 1, 2022

AMR occurs when disease-causing bacteria become resistant or immune to the antibiotics used to treat them. million direct deaths in 2019 and an additional 4.95 If left unchecked, it may soon not be possible to use antibiotics as prophylaxis for immunocompromised patients during chemotherapy or organ transplants.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies Chemotherapy 93

STAT

MARCH 6, 2023

Still, when doctors told her last year that the cancer was growing despite two operations, radiation therapy, and a fifth regimen of chemotherapy, the retired business-meeting facilitator decided to do something unorthodox: spend $83,000 out of pocket on an unproven experimental cancer vaccine. Her husband said he had no regrets.

Vaccines 246

Vaccines Bioethics Immunity Immunization 246

Express Pharma

JANUARY 20, 2025

This therapybenchmarked to global standardsis now available locally to patients for whom conventional therapies including chemotherapy prove ineffective. This therapy harnesses a patients immune cells to target and eliminate cancer, offering new hope to those battling aggressive blood cancers.

Hospitals 105

Hospitals Chemotherapy Immunity Immunization 105